PATENT CLAIM ANALYSIS

Application Number: 16248912
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-07
Patent Classification: ["514", "04400A"]

Abstract:
TNFα antisense oligonucleotides are provided herein. Methods of treating TNFα diseases or disorders using the TNFα antisense oligonucleotides and related products are provided.

Claim (Index 86):
The method of  claim 73 , wherein the antisense oligonucleotide has phosphorothioate internucleotide linkages.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 99.0
- Lexical Diversity: 1.38889
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15517064', '10644052', '14114471', '11748422', '12952863']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7638893353692415
- 35 USC 102 Novelty (BERT): 0.6200742796242642
- Combined Prediction Score: 0.7495078297947438
- Mean Citation Score: 328.277526
- Max Citation Score: 593.3532
- Similarity Product: 485.4078795915127

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test